Cargando…
Effects of Diazepam on Low-Frequency and High-Frequency Electrocortical γ-Power Mediated by α1- and α2-GABA(A) Receptors
Patterns of spontaneous electric activity in the cerebral cortex change upon administration of benzodiazepines. Here we are testing the hypothesis that the prototypical benzodiazepine, diazepam, affects spectral power density in the low (20–50 Hz) and high (50–90 Hz) γ-band by targeting GABA(A) rece...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678188/ https://www.ncbi.nlm.nih.gov/pubmed/31315211 http://dx.doi.org/10.3390/ijms20143486 |
Sumario: | Patterns of spontaneous electric activity in the cerebral cortex change upon administration of benzodiazepines. Here we are testing the hypothesis that the prototypical benzodiazepine, diazepam, affects spectral power density in the low (20–50 Hz) and high (50–90 Hz) γ-band by targeting GABA(A) receptors harboring α(1)- and α(2)-subunits. Local field potentials (LFPs) and action potentials were recorded in the barrel cortex of wild type mice and two mutant strains in which the drug exclusively acted via GABA(A) receptors containing either α(1)- (DZα(1)-mice) or α(2)-subunits (DZα(2)-mice). In wild type mice, diazepam enhanced low γ-power. This effect was also evident in DZα(2)-mice, while diazepam decreased low γ-power in DZα(1)-mice. Diazepam increased correlated local LFP-activity in wild type animals and DZα(2)- but not in DZα(1)-mice. In all genotypes, spectral power density in the high γ-range and multi-unit action potential activity declined upon diazepam administration. We conclude that diazepam modifies low γ-power in opposing ways via α1- and α2-GABA(A) receptors. The drug’s boosting effect involves α2-receptors and an increase in local intra-cortical synchrony. Furthermore, it is important to make a distinction between high- and low γ-power when evaluating the effects of drugs that target GABA(A) receptors. |
---|